GRI Bio, Inc. (GRI) stock
GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.35−0.05 (-3.54%)
Close on Nov 17, 2026Market cap $2.95MP/E –Yield –
GRI Bio cash
Cash and short-term investments held at the end of each period.
GRI Bio's cash was $10.95M at Jun 30, 2026. For fiscal 2025 it was $8.23M, up 63.7% from the year before. The highest annual figure on record is $8.23M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.23M | +63.7% |
| FY2024 | Dec 31, 2024 | $5.03M | +178.1% |
| FY2023 | Dec 31, 2023 | $1.81M | +19988.9% |
| FY2022 | Dec 31, 2022 | $9.00K | -99.9% |
| FY2021 | Dec 31, 2021 | $7.51M | +6789.9% |
| FY2020 | Dec 31, 2020 | $109.00K | -97.1% |
| FY2019 | Dec 31, 2019 | $3.82M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $10.95M | +113.7% |
| Q1 FY2026 | Mar 31, 2026 | $11.05M | +236.7% |
| Q4 FY2025 | Dec 31, 2025 | $8.23M | +63.7% |
| Q3 FY2025 | Sep 30, 2025 | $4.06M | -14.6% |
| Q2 FY2025 | Jun 30, 2025 | $5.12M | -19.4% |
| Q1 FY2025 | Mar 31, 2025 | $3.28M | -19.8% |
| Q4 FY2024 | Dec 31, 2024 | $5.03M | +178.1% |
| Q3 FY2024 | Sep 30, 2024 | $4.75M | +36.1% |
| Q2 FY2024 | Jun 30, 2024 | $6.35M | +32.4% |
| Q1 FY2024 | Mar 31, 2024 | $4.09M | +145.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.81M | +19988.9% |
| Q3 FY2023 | Sep 30, 2023 | $3.49M | -32.3% |
| Q2 FY2023 | Jun 30, 2023 | $4.80M | -31.1% |
| Q1 FY2023 | Mar 31, 2023 | $1.67M | -67.8% |
| Q4 FY2022 | Dec 31, 2022 | $9.00K | -99.9% |
| Q3 FY2022 | Sep 30, 2022 | $5.15M | -43.6% |
| Q2 FY2022 | Jun 30, 2022 | $6.97M | -33.4% |
| Q1 FY2022 | Mar 31, 2022 | $5.18M | -60.1% |
| Q4 FY2021 | Dec 31, 2021 | $7.51M | +6789.9% |
| Q3 FY2021 | Sep 30, 2021 | $9.14M | +889.0% |
| Q2 FY2021 | Jun 30, 2021 | $10.46M | +423.3% |
| Q1 FY2021 | Mar 31, 2021 | $12.98M | +329.2% |
| Q4 FY2020 | Dec 31, 2020 | $109.00K | -97.1% |
| Q3 FY2020 | Sep 30, 2020 | $924.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $2.00M | – |
| Q1 FY2020 | Mar 31, 2020 | $3.02M | – |
| Q4 FY2019 | Dec 31, 2019 | $3.82M | – |
See a number that looks wrong?